The Community Oncology Alliance (COA) is a national nonprofit organization that advocates for independent community oncology practices and the patients they serve. We are the only organization dedicated solely to community oncology. Our mission is to strengthen independent community oncology through advocacy and practice support.

The Community Oncology Alliance (COA) is a national nonprofit organization that advocates for independent community oncology practices and the patients they serve. We are the only organization dedicated solely to community oncology. Our mission is to strengthen independent community oncology through advocacy and practice support.

Featured from COA

Upcoming Events

Join professionals and advocates from across the country at one of our informative events.

1782400194546 myCOA banner CAN COPA membershipcalls

CAN & COPA Monthly Membership Meeting - July 23, 2026

Loading... Loading...
1782414116834 COA webinar image large event COA

Introducing the COA AI Playbook Round 2: A Framework for Evaluating and Implementing AI in Community Oncology

Loading... Loading...
1759242473800 mycoa banner COPA membershipcalls

COPA Monthly Membership Meeting Call - August 13, 2026

Loading... Loading...

Latest Updates & News

Structural Vulnerability in the United States Radiation Oncology Delivery System: Predictors and Consequences of Practice Site Disappearance

Published On: July 10th, 2026

We sought to identify predictors of radiation oncology (RO) practice-site disappearance in the United States between 2018-2025, characterize how turnover reshapes county-level treatment capacity, and understand how counties with versus without RO access in 2025 differed in terms of sociodemographic and health system features.

Read More

Why cancer patients are paying full price for drugs

Published On: July 10th, 2026

When I was diagnosed with Triple Negative Breast Cancer, my first thought was not policy. It was survival.

Read More

Let Doctors Choose the Right Medicare Treatments

Published On: July 10th, 2026

Every day, providers see firsthand how coverage and access decisions shape whether patients with rheumatoid arthritis can continue treatments that control their disease or spiral into avoidable pain and disease progression.

Read More